'Percutaneous coronary intervention' presentation slideshows

GNL 2011

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization). GNL 2011. GNL 2011. Slide Set Organization. COR and LOE General Revascularization (CABG or PCI) Recommendations PCI Revascularization Recommendations Pre-Procedural Considerations

924 views • 69 slides

Management of Coronary Artery Disease

758 views • 58 slides

RECOMMENDATIONS

Canadian Cardiovascular Society Anti Platelet Guideline 2010.

492 views • 40 slides

Hyo-Soo Kim MD, PhD on behalf of the investigators Seoul National University Hospital, Seoul, Korea

E fficacy of X ience /Promus versus C ypher to r E duce L ate L oss in st ENT. Hyo-Soo Kim MD, PhD on behalf of the investigators Seoul National University Hospital, Seoul, Korea. Disclosure Statement of Financial Interest.

545 views • 29 slides

Physician Prognostic Accuracy for In-Hospital Mortality in Percutaneous Coronary Intervention

443 views • 29 slides

Diagnosis and Management of Shock

Diagnosis and Management of Shock. Dr. Anas Khan Consultant, EM MBBS, MHA, ArBEM 428 C2 notes. Objectives. Identify the 4 main categories of shock. Discuss the goals of resuscitation in shock. Summarize the general principles of shock management.

930 views • 28 slides

CORONARY ARTERY DISEASE OVERVIEW Pathogenesis, Clinical Features, Diagnostic Testing and Therapy

CORONARY ARTERY DISEASE OVERVIEW Pathogenesis, Clinical Features, Diagnostic Testing and Therapy. Hank George, FALU, CLU, FLMI.

478 views • 27 slides

CORONARY ARTERY DISEASE OVERVIEW Pathogenesis, Clinical Features, Diagnostic Testing and Therapy

CORONARY ARTERY DISEASE OVERVIEW Pathogenesis, Clinical Features, Diagnostic Testing and Therapy. Hank George, FALU, CLU, FLMI.

275 views • 27 slides

Friedrich W. Mohr MD PhD Patrick W. Serruys MD PhD On behalf of the SYNTAX investigators

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries. Friedrich W. Mohr MD PhD Patrick W. Serruys MD PhD On behalf of the SYNTAX investigators. Conflicts of Interest: None. Background l.

435 views • 24 slides

CMS Core Measures

CMS Core Measures. Evidence-Based Performance Measurement. What is Evidence-Based Medicine?. Patient care that research has shown to result in better outcomes for patients, such as lower: ? mortality and morbidity ? disability ? length of stay ? readmissions. What is a core measure?.

750 views • 22 slides

339 views • 22 slides

353 views • 21 slides

Gregg W. Stone MD For the AMIHOT II Investigators

A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction. Gregg W. Stone MD For the AMIHOT II Investigators. Disclosures. Gregg W. Stone MD Research support from TherOx Inc. Background.

416 views • 12 slides

Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention

494 views • 11 slides

Patient-centered, Purposeful Public Reporting

Patient-centered, Purposeful Public Reporting. David Share, MD, MPH vice president, Value Partnerships Blue Cross Blue Shield of Michigan dshare@bcbsm.com. Purpose: Empowering Consumers to be Full Partners in Their Care. Information/knowledge = power

198 views • 8 slides

Growth Opportunities in Embolic Protection Devices Market

The report "European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) - Forecast to 2024" The European mammography workstations market is projected to reach USD 14 million by 2024 from USD 10 million in 2018, at a CAGR of 5.5% during the forecast period. Read More: https://www.marketsandmarkets.com/PressReleases/european-mammography-workstation.asp

45 views • 3 slides

Background and Objectives

Background and Objectives. Materials and Methods.

156 views • 1 slides